First National Corp’s Novo Nordisk NVO Stock Holding History

First National Corp’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,334	Closed	-$432K	–	155
2023 Q2	$432K	Hold	5,334	–	–	0.1%	117
2023 Q1	$424K	Buy	+5,334	New	+$378K	0.1%	119

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First National Corp's NVO Position: Q3 2023 in Review

First National Corp sold out of Novo Nordisk (NVO) in Q3 2023, closing a stake of 5,334 shares — an estimated $432K sold.

First National Corp first reported a position in NVO in Q1 2023 and held it in 2 quarters. The position peaked at $432K in Q2 2023. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

First National Corp reported no remaining Novo Nordisk position as of Q3 2023 after selling out during the quarter.
First National Corp sold 5,334 Novo Nordisk shares in Q3 2023, an estimated $432K.
First National Corp first reported a position in Novo Nordisk in Q1 2023 and held it in 2 quarters.
First National Corp's Novo Nordisk position peaked at $432K in Q2 2023.
1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on First National Corp's 13F filing for Q3 2023, filed 24 Oct 2023.